WE expect a lot from our breakfast – tasty, quick, on-the-go and cheap. So it’s no wonder that “healthy” often drops off the ...

A nurse has revealed exactly what you need to be drinking when you're on a GLP-1 medication - and why hydration on the ...

Ozempic and other semaglutide medications (including Wegovy and Rybelsus) have changed the lives of millions of Americans ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Medical professionals point out that functional impairment in individuals with PAD is often overlooked in its early stages ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...

Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...